HCPCS Level II
J0588
Injection, incobotulinumtoxin a, 1 unit
Codes near J0588
These sit next to J0588 in the CMS Level II file. All J codes
- J0583Injection, bivalirudin, 1 mg
- J0584Injection, burosumab-twza 1 mg
- J0585Injection, onabotulinumtoxina, 1 unit
- J0586Injection, abobotulinumtoxina, 5 units
- J0587Injection, rimabotulinumtoxinb, 100 units
- J0589Injection, daxibotulinumtoxina-lanm, 1 unit
- J0591Injection, deoxycholic acid, 1 mg
- J0592Injection, buprenorphine hydrochloride, 0.1 mg
- J0593Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
- J0594injection, busulfan, 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00259-1605-01 | Xeomin | Merz Pharmaceuticals, LLC | 50 |
| 00259-1610-01 | Xeomin | Merz Pharmaceuticals, LLC | 100 |
| 00259-1620-01 | Xeomin | Merz Pharmaceuticals, LLC | 200 |
| 46783-0160-01 | Xeomin | Merz North America, Inc. | 100 |
| 46783-0161-01 | Xeomin | Merz North America, Inc. | 50 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.